Filing Flows › Regenerative Medical Technology Group (RMTG) › Q2 2026 › vs Q2 2025
Regenerative Medical Technology Group (RMTG) Q2 2026 vs Q2 2025 (year over year)
Regenerative Medical Technology Group's revenue rose $3.0M (+309%) from $983K in Q2 2025 to $4.0M in Q2 2026.
Regenerative Medical Technology Group, Q2 2026: revenue $4.0M (+309% year over year), operating margin 14.1%, net loss $2.9M, operating cash flow $332K. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $4.0M | $983K | $3.0M | +309% |
| Net loss | $2.9M | $1.4M | $1.5M | +101% |
| Costs & expenses | $6.9M | $2.4M | $4.5M | +185% |
| Operating costs | $3.5M | $1.2M | $2.2M | +180% |
| Interest & other, net | $3.5M | $1.2M | $2.3M | +191% |
| Cost of revenue | $1.4M | $398K | $1.0M | +263% |
| Sales & marketing | $547K | $148K | $399K | +270% |
| General & admin | $619K | $207K | $412K | +198% |
| Other operating costs | $846K | $481K | $366K | +76% |
| Operating cash sources | $3.2M | $845K | $2.4M | +283% |
| Depreciation & amortization | $91K | $55K | $36K | +66% |
| Working capital & other | $3.1M | $791K | $2.4M | +298% |
| Net loss absorbed | $2.9M | $1.4M | $1.5M | +101% |
| Operating cash flow | $332K | −$598K | $930K | — |
Questions
How much did Regenerative Medical Technology Group's revenue grow year over year in Q2 2026?
Regenerative Medical Technology Group's revenue rose $3.0M (+309%) from $983K in Q2 2025 to $4.0M in Q2 2026.